UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 320

Sortiert nach

Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab

PloS one, 2024-02, Vol.19 (2), p.e0293264-e0293264

2024

Volltextzugriff (PDF)

Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

Journal of clinical pharmacy and therapeutics, 2013-02, Vol.38 (1), p.41-47

2013

Volltextzugriff (PDF)

Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments

PloS one, 2017-05, Vol.12 (5), p.e0177364-e0177364

2017

Volltextzugriff (PDF)

The cost‐effectiveness of dapagliflozin compared to DPP‐4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands

Diabetic medicine, 2021-04, Vol.38 (4), p.e14371-n/a

2021

Volltextzugriff (PDF)

Developing a decision tool to identify patients with personality disorders in need of highly specialized care

BMC psychiatry, 2017-08, Vol.17 (1), p.317-317, Article 317

2017

Volltextzugriff (PDF)

Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck

European archives of oto-rhino-laryngology, 2015-08, Vol.272 (8), p.2007-2016

2015

Volltextzugriff (PDF)

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial

BMC cancer, 2018-11, Vol.18 (1), p.1146-1146, Article 1146

2018

Volltextzugriff (PDF)

Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma

BMC medical research methodology, 2023-05, Vol.23 (1), p.132-132, Article 132

2023

Volltextzugriff (PDF)

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits

Vaccine, 2005-03, Vol.23 (17), p.2379-2387

2005

Volltextzugriff (PDF)

Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer

European journal of cancer (1990), 2017-04, Vol.75, p.204-212

2017

Volltextzugriff (PDF)

Costs of Prostate Cancer, Metastatic to the Bone, in The Netherlands

European urology, 2003-03, Vol.43 (3), p.226-232

2003

Volltextzugriff (PDF)

The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population

Prostate cancer and prostatic diseases, 2021-09, Vol.24 (3), p.871-879

2021

Volltextzugriff (PDF)

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens

Annals of hematology, 2018-02, Vol.97 (2), p.255-266

2018

Volltextzugriff (PDF)

Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study

Quality of life research, 2015-12, Vol.24 (12), p.2895-2906

2015

Volltextzugriff (PDF)

Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study

British journal of haematology, 2001-08, Vol.114 (2), p.319-326

2001

Volltextzugriff (PDF)

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry

BMC cancer, 2016-06, Vol.16 (1), p.364-364, Article 364

2016

Volltextzugriff (PDF)

Cost-effectiveness of rituximab (MabThera®) in diffuse large B-cell lymphoma in the Netherlands

European journal of haematology, 2005-03, Vol.74 (3), p.194-202

2005

Volltextzugriff (PDF)

Health related quality of life in patients with multiple myeloma undergoing a double transplantation

European journal of haematology, 2005-02, Vol.74 (2), p.136-143

2005

Volltextzugriff (PDF)

A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma: a prospective randomised phase III study

European journal of cancer (1990), 2004-05, Vol.40 (8), p.1159-1169

2004

Volltextzugriff (PDF)

Cost-effectiveness of red blood cell transfusion vs. non-intervention in women with acute anaemia after postpartum haemorrhage

Vox sanguinis, 2014-11, Vol.107 (4), p.381-388

2014

Volltextzugriff (PDF)

CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma

Journal of clinical oncology, 2003-08, Vol.21 (16), p.3041-3050

2003

Volltextzugriff (PDF)

Real-world resource use and costs of adjuvant treatment for stage III colon cancer

European journal of cancer care, 2015-05, Vol.24 (3), p.321-332

2015

Volltextzugriff (PDF)

Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma

Quality of life research, 2018-01, Vol.27 (1), p.115-124

2018

Volltextzugriff (PDF)

An implantable device to treat multiple sclerosis: A discrete choice experiment on patient preferences in three European countries

Journal of the neurological sciences, 2021-09, Vol.428, p.117587-117587, Article 117587

2021

Volltextzugriff (PDF)

Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review

Multiple sclerosis and related disorders, 2020-04, Vol.39, p.101929-101929, Article 101929

2020

Volltextzugriff (PDF)

1 – 25 von 320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(304)
Mit Volltextzugriff
(304)

Publikationsform

Artikel
(320)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab

Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments

The cost‐effectiveness of dapagliflozin compared to DPP‐4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands

Developing a decision tool to identify patients with personality disorders in need of highly specialized care

Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial

Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits

Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer

Costs of Prostate Cancer, Metastatic to the Bone, in The Netherlands

The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens

Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study

Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study

Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry

Cost-effectiveness of rituximab (MabThera®) in diffuse large B-cell lymphoma in the Netherlands

Health related quality of life in patients with multiple myeloma undergoing a double transplantation

A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma: a prospective randomised phase III study

Cost-effectiveness of red blood cell transfusion vs. non-intervention in women with acute anaemia after postpartum haemorrhage

CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma

Real-world resource use and costs of adjuvant treatment for stage III colon cancer

Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma

An implantable device to treat multiple sclerosis: A discrete choice experiment on patient preferences in three European countries

Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review

Suchergebnisse filtern